225517-86-2 Usage
Uses
Used in Pharmaceutical Industry:
Boronic acid, [2-(cyclopropyloxy)phenyl]is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity facilitate the development of new drugs with improved efficacy and selectivity.
Used in Agrochemical Industry:
In the agrochemical sector, Boronic acid, [2-(cyclopropyloxy)phenyl]serves as a vital component in the production of agrochemicals. Its application contributes to the creation of more effective and targeted pesticides and other agricultural products.
Used in Material Science:
Boronic acid, [2-(cyclopropyloxy)phenyl]is employed as a building block in the development of new materials with specific properties. Its integration into material compositions can enhance performance characteristics such as strength, flexibility, and chemical resistance.
Used in Organic Synthesis:
As a versatile chemical reagent, Boronic acid, [2-(cyclopropyloxy)phenyl]is extensively used in organic synthesis for the formation of carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions. This application is crucial for constructing complex molecular structures and advancing the synthesis of a wide range of organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 225517-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,5,5,1 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 225517-86:
(8*2)+(7*2)+(6*5)+(5*5)+(4*1)+(3*7)+(2*8)+(1*6)=132
132 % 10 = 2
So 225517-86-2 is a valid CAS Registry Number.
225517-86-2Relevant articles and documents
INTEGRIN INHIBITORS
-
Paragraph 0171-0172, (2020/03/17)
Disclosed are small molecule inhibitors of αvβ6 integrin, and methods of using them to treat a number of diseases and conditions.
Substituted β-alanine derivatives as cell adhesion inhibitors
-
, (2008/06/13)
β-Alanine derivatives of Formula I are antagonists of VLA-4 and/or α4β7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.
